Raffles Medical Likely a Defensive Option Amid Volatility -- Market Talk

Dow Jones

04-08

0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. (ronnie.harui@wsj.com)

(END) Dow Jones Newswires

April 07, 2025 23:39 ET (03:39 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2525870887"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2525870887\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2525870887?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-08 11:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2525870887","market":"sg","top_or_hot":-1,"title":"Raffles Medical Likely a Defensive Option Amid Volatility -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 07, 2025 23:39 ET (03:39 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raffles Medical Likely a Defensive Option Amid Volatility -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaffles Medical Likely a Defensive Option Amid Volatility -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-08 11:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 07, 2025 23:39 ET (03:39 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSL.SI","symbol_name":"莱佛士医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2525870887","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2525870887","pubTimestamp":1744083540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSL.SI":"莱佛士医疗","BK6511":"医疗保健服务概念","BK6092":"保健护理机构"},"translate_title":"莱佛士医疗可能是波动中的防御性选择——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSL.SI":1},"content_text":"0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. (ronnie.harui@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 07, 2025 23:39 ET (03:39 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}